Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-equol in Alzheimer's disease
NCT02142777Phase 1Completed
- Sponsor
- Russell Swerdlow
- Start
- Jul 2014
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing S-equol Arm with Placebo Arm (2 arms). Primary endpoint: Platelet mitochondria cytochrome oxidase activity at 6 weeks. Started Jul 2014; status: completed.
02
Drugs
s-equol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02142777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142777.